Insight into the biomechanics of human-device interaction Numalogics virtual lab provides insight into the biomechanics of human-device interaction. Simulation, Biomechanics, sportsgear, and medical devices

77 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Evolutionary Cytokines | Revolutionary Medicines | TSX: MDNA | OTCQX: MDNAF Medicenna is a clinical stage immunotherapy company focused on the development of novel, highly selective versions of IL-2, IL-4 and IL-13 Superkines and first in class Empowered Superkines. Medicenna's long-acting IL-2 Superkine, MDNA11, is a next-generation IL-2 with superior CD122 binding without CD25 affinity thereby preferentially stimulating cancer killing effector T cells and NK cells. Medicenna’s early-stage BiSKITsTM program, (Bifunctional SuperKine ImmunoTherapies) is designed to enhance the ability of Superkines to treat immunologically “cold” tumors. Medicenna's IL-4 Empowered Superkine, MDNA55, has been studied in 5 clinical trials including a …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Next Generation Biofabrication - Sound Induced Morphogenesis //Acoustic biofabrication MimiX biotherapeutics introduces Sound Induced Morphogenesis. We extend the boundaries of biofabrication, making bioengineered, artificial human organs and tissues a future reality. Sound Induced Morphogenesis (SIM) is a revolutionary approach in biofabrication. It mirrors nature’s design, to aggregate and pattern biologicals by tuning sound profiles under contactless, fast and delicate culture conditions resulting in a morphologically induced tissue generation. We introduce cymatiX®, a unique acoustic biofabrication solution that makes the Sound Induced Morphogenesis technology easily accessible to the scientific and clinical community Visit www.mimixbio.com to learn more. mimiX biotherapeutics is a …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Created in 2017, Cyprio is founded on ten years of research at the prestigious French institute for higher education in science and engineering, Ecole Supérieure de Physique et Chimie Industrielles de la ville de Paris (ESPCI Paris), with a strong expertise in the field of 3D cell culture, liver biology and drug development. This makes Cyprio the holder of a unique technology for fabrication of alginate liquid-core capsules containing 3D cellular models physiologically more relevant than traditional monolayer cell culture and compatible with high throughput screening applications. Our first product "HepatoPearl" has been validated as a beneficial in vitro liver …

11 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Treatment of chronic pathologies by non-invasive neurostimulation Manufacturer of neuronavigators for TMS, Syneika offers therapeutic solutions to alleviate chronic neurological and psychiatric diseases using a non-invasive neurostimulation technique: neuronavigated Transcranial Magnetic Stimulation (TMS). Syneika One, the neuronavigator designed by Syneika, was developed in collaboration with doctors and nurses. It is a fully integrated neuronavigator offering precision and ease of use in daily work. Syneika One neuronavigation for TMS aims to make repetitive Transcranial Magnetic Stimulation therapy accessible to any care team. It has been designed to fit the time constraints of an intensive therapeutic activity. To this end, powerful algorithms …

Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology

Proteins Structures Got Easier With Crystallophores Emerged from academic research, POLYVALAN (IBS & ENS Lyon Spin-off company) is a young innovative company founded in December 2016 dedicated to structural biology. POLYVALAN competitive edge is its unique chemical approach allowing significant gain of effectiveness, time and/or precision for protein structure determination that allows an optimal use of the existing large equipments. structural biology, protein crystallization, crystallization screening, nucleating agent, phasing agent, crystallophore, structure determination, X-ray crystallography, and drug design

59 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

To make syringe injections disappear! Vitropep customizes soluble microneedles patches made of biomaterials for transdermal injection

Type: Startup Activities: greentech Technologies: Synthetic Biology

Visionary science. CTIBiotech, models for your research. CTIBiotech uses advanced tissue engineering techniques (3D bioprinting, bioreactors) to develop models and bioassays needed to test the efficiency and effect of ingredients. Our models have varying levels of complexity suited our clients needs in the pharmaceutical industry and dermato-cosmetics sectors. We also work in partnership to co-develop new models that fit a specific requirement. The CTIBiotech Biobank is accredited by French authorities and we can offer human tissues, primary cells, cell lines and tumours. We currently store around 30 000 samples, from 0-94 years and from different ethnical backgrounds. Our customers come …

4 similar entities Type: Startup Activities: biotech deeptech Technologies: 3D Printing Synthetic Biology

Biology x AI-powered drug development platform to transform precision oncology. Orakl Oncology leverages a unique collection of patient tumor avatars that combines biology and clinical data to fuel the therapeutic arsenal to fight cancer. With our platform we partner with oncology players to identify relevant targets and deliver new drugs, faster.

64 similar entities Type: Startup Activities: biotech deeptech Technologies: Data Analytics Synthetic Biology

Diagnostics for better care, everywhere. Diagnostics for Better care, Everywhere. En Carta Diagnostics is a synthetic-biology biotech company leveraging patented technologies to decentralise highly reliable molecular diagnostic solutions. synthetic biology, cell-free, biotech, and molecular sensing

60 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

A regenerative medecine company Healshape is a regenerative medecine project. We aim at developing breast regeneration solutions by 3D bioprinting for women who had mastectomy following breast cancer. Biotechnology, Regenerative medecine, Médecine régénérative, Reconstruction mammaire, Cancer du sein, Breast cancer, Breast regeneration, Breast reconstruction, 3D bioprinting, Tissue engineering, Biologie cellulaire, Impression 3D, Funds raising, and Tissue engineered products

61 similar entities Type: Startup Activities: deeptech Technologies: 3D Printing Synthetic Biology

Over 20 years of experience dedicated to intraocular lenses manufacturing To design, develop and distribute innovative solutions in eye surgery contributing to patient well-being. We have over 20 years of experience dedicated to IOL manufacturing. Opthalmology, Intraocular Lenses, Medical Devices, Surgical, Cataract, Vitreoretinal, and Cornea

41 similar entities Type: Startup Activities: healthtech Technologies: Synthetic Biology

A New Approach to treat Sleep Apnea Pasithea: A New Approach to Sleep Apnea Pasithea introduces a novel and groundbreaking non-invasive adaptive neuromodulation approach to address respiratory disorders. The applied stimulation elicits a response from the autonomic nervous system in the early phases of apnea. Clinical studies have shown that Pasithea's therapy is safe and well-tolerated, and that it can significantly improve respiratory disorders. The therapy is also non-invasive, which means that it does not require surgery or hospitalization.

Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology

Targeting protein interactions for health Founded in 2023, TheraPPI Bioscience is a biotechnology company whose science originates from the CRCL (Centre de Recherche de Cancérologie de Lyon, France). We modify protein interactions to offer treatments where current therapies fail. Our approach represents a paradigm shift in tackling cancer resistance and non-curable rare diseases protein-protein interaction, PPI, small molecule, therapeutics, oncology, and rare disease

80 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Relief of heat puffs by cryotherapy Athana is a french start-up specializing in the commercialization of innovative solutions for women's natural well-being, Particularly for those suffering from the effects of menopause. We focus on improving quality of life by offering natural and effective alternatives to hormonal treatments, which are often associated with health risks. Our mission is to alleviate hot flashes, the most debilitating symptom of menopause, Affting 900 million Women Worldwide. To add this need, we have developed Two Flagship Products: Hera, a Portable Device That Uses Cryotherapy to Provid Instant Relief from Hot Flashes, and Moona, A Connected …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

Rebalancing the immune system, resolving inflammation. Drug candidates from our molecular platforms normalize the immune system by downregulating pro-inflammatory immune response and upregulating regulatory immune response. IMD-Pharma S.A.S is a french biotechnology company conducting research and development of innovative drug candidates for immune-related inflammatory diseases. Founded in 2016, IMD-Pharma is a company from the Laboratoire de Chimie de Coordination (CNRS) and the Centre de Physiopathologie de Toulouse Purpan (INSERM/CNRS/Université Toulouse III). immuno-modulation, anti-inflammatory drugs, chronic inflammatory diseases, Multiple Sclerosis, Rheumatoid Arthritis, dendrimers, monocyte rehabilitation, and psoriasis

49 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Disruptive solutions for image guided therapies Certis Therapeutics develops and markets minimally invasive thermo-ablation solutions. These solutions are controlled by real time MRI images including accurate 3D temperature maps and deliver treatments for cardiological, oncological and neurological diseases. The company aims at providing best in class solutions delivering significantly higher efficacy and safety as to current standards of care. medical device, oncology, cardiology, MRI guided, and Thermal ablation

40 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

At Corlieve, we are focused on bringing novel therapeutic options to patients with severe neurological disorders. Corlieve Therapeutics, a fully owned subsidiary of UniQure, is a biotechnology company focused on bringing novel therapeutic options to patients with severe neurological disorders.

60 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Laboratory for the Bioengineering of Tissues (Mixed Research Unit: Inserm and Bordeaux University) The BioTis laboratory (Laboratoire de Bioingénierie Tissulaire – Laboratory for the Bioengineering of Tissues) is a “Mixed Research Unit” (#1026) that is comprised of personnel from the INSERM, the French national institute of health and medical research), and from the University of Bordeaux. The Unit is located on the 5th floor of the new Bordeaux Biologie Santé (BBS) building at the University of Bordeaux medical campus. BioTis has around 65 members including full time researchers, junior and senior professors in medicine/medical sciences, technical and support staff, post-doc …

27 similar entities Type: Public Research & Education Startup Activities: deeptech Technologies: Synthetic Biology

By mixing the scientist and the clinic, Emopsy offers new tools for assessing emotional skills for psychologists.

Type: Startup Activities: deeptech Technologies: Synthetic Biology

Reinventing orthopedics BoneTag is a french start-up, based in Montpellier, which is focused on the development of innovative medical devices in orthopedics. BoneTag is developing two medical devices: • INCESSU: A solution making total knee arthroplasties (TKA) smart and connected. This medical device allows the communication between the implanted TKA and the surgeon. The communicated data are: identification information about the TKA, temperature in contact with the bone and motion between the TKA and the bones. • KNEEMATICS: A dynamic 3D representation of the kinematics of total knee arthoplasties. This device allows the visualization in real-time, and in 3D, of …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology IoT

MAAsiRNA develops a pioneering targeted therapy utilizing small interfering RNA (siRNA). A significant challenge in the field of nervous system pathologies lies in the absence of effective treatments. MAAsiRNA develops a pioneering targeted therapy utilizing small interfering RNA (siRNA). After over a decade of intensive interdisciplinary research, we have successfully developed a siRNA-based treatment for Charcot-Marie-Tooth disease type 1A (CMT1A), the most prevalent form of hereditary peripheral neuropathy. CMT1A affects 1 in 5000 people, comprising a total of 1.5 million individuals worldwide. Our current objective is to advance towards a patient-ready therapy. Our innovative therapeutic approach has the potential to …

Type: Startup Activities: healthtech deeptech biotech Technologies: Synthetic Biology

Blue Bees Therapeutics develops immunomodulatory proteins with therapeutic potential to fight cancer Blue Bees Therapeutics is a biotechnology company founded in March 2022, dedicated to the development of first-in-class immunotherapies for the treatment of cancers, based on a breakthrough technology discovered by the team led by Dr Michel Léonetti, within the Department of Pharmacology and Immunoanalysis from CEA Paris-Saclay. This technology allows to generate antibodies stimulating the anti-tumor immune response via a double cell receptor targeting coupled with heparan sulphate proteoglycans (HSPG). Immunothérapie, Immuno-oncologie, pharma, Biotech, Immunologie, Oncologie, Cancer, Médicament, and Drug

176 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Advanced Antibody Expertise Deeptope's expertise lies in antibody charaterisation (epitope/paratope mapping) and optimisation using high throughput methods. antibody, paratope mapping, epitope mapping, and antibody optimisation

77 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Innovative biosensing solutions for diagnostic and pharmaceutical companies, leveraging our K-One® surface chemistry. We are a team of chemists and biosensor engineers gathered around a common mission: shaping the future of biodetection for a better world. Kimialys is the result of 10 years of meticulous academic research in surface chemistry. Controlling what is happening on the surface is a fundamental aspect of biosensing techniques such as rapid tests, point-of-care diagnostics, and real-time sensors. Without the right surface interactions, even the most advanced biosensors can falter, leading to misleading results. Our research efforts have always been to optimize these crucial parameters, …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

New view for cancer Therapeutic Sirius Neosight is an innovative technological breakdown company which aims to become a key player in the detection of subclashed neo-cancers, relapses and therapeutic monitoring of patients thus offering a new look to doctors on the therapeutic efficiency implemented. Sirius Neosight operates a patented from a patented rupture technology from a consortium of academic laboratory experts in the field.

59 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Ultrasound Cyclo Plasty = Focused, Adaptable, Proven EYE TECH CARE, based in Lyon, was founded in 2008 by experts in the field of therapeutic ultrasound. The company develops and markets medical devices for the non invasive treatment of eye diseases. Glaucoma and ocular hypertension affect some 12O million people around the world, but are diagnosed in only about 30% of cases. It is the second cause of blindness, according to WHO (World Health Organization). With the support of renowned scientific and financial partners, EYE TECH CARE has developed the EyeOP1, an unique therapeutic device. Its teams have designed the only …

7 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Explore Understand Innovate LBTI is a leading French research laboratory specializing in the study of healthy and diseased tissues and in the development of innovative therapeutic strategies with high potential for translation toward clinical applications. We have strong expertise in human skin, cartilage and mucosae. Our specific research aims are: > to analyze the basic mechanisms of tissue organization and homeostasis, and to identify potential therapeutic targets > to understand and model the tissue response to physiological or pathological stress (including mechanical stress and aging) > to develop novel therapeutic approaches for tissue repair and targeted delivery of therapeutic agents …

17 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Innovative therapies for peripheral nerve diseases Nervosave Therapeutics discovers and develops therapies that slow, stop and reverse a broad range of demyelinating peripheral nerve diseases. Our first aim is to develop best in class Gene Therapy for CMT1A patients and beyond for all demyelinating CMT diseases. We develop robust discovery programs targeting both CMT diseases and acquired demyelinating peripheral neuropathies such as diabetic peripheral neuropathy and Guillain-Barré syndrome.

9 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Stent'Up vise à sécuriser le traitement préventif des anévrismes cérébraux par la création d'un implant révolutionnaire. Stent Up, designs, manufactures, and markets medical devices dedicated to the treatment of strokes.

48 similar entities Type: Startup Activities: manufacturing healthtech deeptech Technologies: Synthetic Biology

We improve your enzymes. Catsalyze will revolutionize enzymatic biocatalyze. Our proprietary technology allows us to graft enzymes around a protein ring, which gives them strong advantages such as increased stability, solubility, efficiency but also the possibility of assembling these grafted rings to create perfectly colocalized enzymatic cascades. . So extremely effective. Our challenge? Transform biomass in a gentle and clean way and through accelullar enzymatic catalysis into chemical bricks classically petrosourced and synthesized with pollution. The future of chemistry passes through Catsalyze.

Type: Startup Activities: deeptech greentech Technologies: Synthetic Biology

Soft culture plates for pleased cells Cell&Soft is a young french biotech located in the AURA region, in Grenoble city. Born from a joint project between LTM Lab (CNRS) and CEA BIG, Cell&Soft is specialized in the development, production and sale of soft and biomechanical substrates for in vitro cell culture. Cell&Soft offers solutions to enhance the physiology and the relevance of cell culture and cell-based assays. biotechnology, cell culture, soft substrates, culture plates, cell-based assays, biotech, in vitro, drug discovery, stem cells, controlled rigidity, controlled stiffness, and petri dish

35 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Pioneering thymus-empowered T-cell platform to fight cancer and infection Smart Immune is a clinical-stage French biotechnology company developing ProTcell, a thymus-empowered T cell progenitor platform to fully and rapidly re-arm the immune system against cancer and infection, enabling next-generation allogeneic T cell therapies. The company aims to radically improve outcomes for patients in hematology and immune-oncology. Smart Immune has ongoing collaborations with leading institutions in the US and Europe. SMART101 is in Phase I/II clinical trials in cancer patients with AML and ALL, in SCID in the EU and the US. Smart Immune is also developing therapies using gene-modified T …

57 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Revolutionizing healthcare with exosomes focusing on gastrointestinal, liver and kidney regeneration EverZom is an exosome biotech company developing treatments for digestive tissue healing like Crohn's fistula and organ regeneration like the kidney and the liver. Founded in 2019, EverZom is positioned to become the leader of exosome therapeutics, the next wave of innovation for the biotech industry. Exosomes, small vesicles secreted by cells, are increasingly recognized as potent agents for intercellular communication and play a crucial role to treat a wide range of diseases. Winner of the European EIC Accelerator Program, EVerZom aims to be the upcoming pioneer in this …

2 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

MAKING HEARING A PRIORITY CILCARE is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment. We believe hearing acts as a valuable indicator of our health and must be monitored and preserved accordingly. As awareness of the link between hearing and chronic health conditions grows, auditory sciences are paving the way for the early detection of chronic neurocognitive, inflammatory, and age-related diseases. CILCARE External Innovation supports its partners in the health and life-sciences sector in the development of new therapies to prevent and treat auditory-related diseases including inherited hearing loss, …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

From Molecules to Medicine and Beyond NMR-Bio is a CRO located in Grenoble (France), one of the most vibrant European hubs for structural biology and supplies compounds for the selective labelling of methyl groups in perdeuterated proteins. NMR-Bio also offers a broad range of services for NMR applications: - Custom labelled protein production in bacteria, cell-free system, insect cells, HEK293 and CHO cells - Solution for labelling of your biopharmaceutics especially mAbs and Fabs - High-field NMR data acquisition and analysis (e.g. quality control, spectra assignment, structure calculation, dynamic characterisation).

59 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Develops innovative technological systems for skin care intended for home use. Lightinderm is a French start-up hosted at Cochin Hospital in Paris, which develops innovative technological systems for skin care for home use. Inspired by dermatological treatments, its multi-brewed innovation associates photobiomodulation for the first time, photo-assets capsules and tissue massages. This unique association activates the natural regeneration of cells and visibly improves the quality of the skin. 9 years of research - 43 patents - 7 clinical studies Medical Device and Cosmetics

19 similar entities Type: Startup Activities: deeptech healthtech manufacturing cosmetics Technologies: Synthetic Biology

We created Rondol Industrie in 2012 with the goal of adapting Hot Melt Extrusion (HME) technology to the micro scale and to pharma standards and contributing therefore to better and cheaper healthcare. We are now HQ'd in Nancy, France. Rondol is a privately owned Deeptech company which patented the All-in-One Vertical twin screw extruder, representing a significant innovation in pharmaceutical manufacturing due to its capacity to increase the efficiency of drug formulation and delivery, and allowing for more effective therapeutic solutions. What sets this technology apart is its ability to handle complex formulations, enhance drug solubility, and improve bioavailability. These …

Type: Startup Activities: it services manufacturing Technologies: Synthetic Biology

Human PK data from preclinical stages BrainPlotting is a french contract research organization company which offers his knowledge to predict the entrance of drugs into the brain To that end BrainPlotting developped in vitro models based on fresh human tissus and cells. BrainPlotting is incubated at the Brain and Spine Institute (ICM), Paris, France Our core business is the study of pharmacokinetics (PK) in the human brain. The molecules that we study can have CNS targets as well as peripheral targets. To study the brain's PK, BrainPlotting uses the most accurate predictive models and the most recent methods and tools. …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Advancing peptides for the treatment of rare endocrine and related diseases Amolyt Pharma is building on its team’s established expertise to deliver life-changing treatments to patients suffering from rare endocrine and related diseases. Amolyt Pharma’s portfolio includes eneboparatide (AZP-3601), a long-acting PTH1 receptor agonist as a potential treatment for hypoparathyroidism, and AZP-3813, a peptide growth hormone receptor antagonist for the potential treatment of acromegaly. Amolyt Pharma aims to further expand and develop its portfolio by leveraging its global network in the field of endocrinology and with support from a strong syndicate of international investors. Hypoparathyroidism, Endocrinology, Metabolic Disease, Therapeutic Peptides, …

3 similar entities Tags: FrenchTech2030 Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Biomorphic Programmable Polymers TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function. Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas. Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices. We have developed a fully …

83 similar entities Tags: FrenchTech120 Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Discovery of novel immune checkpoint inhibitors for cancer immunotherapy OREGA Biotech specializes in the discovery and the development of first-in-class monoclonal antibodies for cancer immunotherapy. The company was incepted in 2010 and is managed by Jeremy Bastid, CEO and Gilles Alberici, President. The science at OREGA Biotech is based on the research conducted by its academic cofounders Nathalie Bonnefoy, Armand Bensussan and Jean-François Eliaou. Our in vivo screening approach aims at discovering and validating novel immune checkpoint inhibitors and regulators of anti-PD1 response. Our lead asset, an anti-CD39 monoclonal antibody, has been out-licensed to Innate (2016) Pharma and then partnered …

69 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Kallistem is a biotech company specialized in spermatogenesis. The company was founded in 2012 with the objective to anticipate and treat male infertility. It promotes a technology and expertise developed by Philippe Durand and Marie-Helene Perrard, two internationally renowned scientists in the field of the reproductive biology and more specially in in vitro spermatogenesis. Kallistem has developed, in collaboration with its partners, original and innovating technologies of germinal cell culture for male fertility preservation and the treatment of male infertility. male fertility, cellular therapy, biology of reproduction, and testicular toxicology

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Your pharmaceutical industry’s partner, from OEM subcontracting to the design & manufacture of injected medical devices. SGH Medical Pharma results from the alliance of 3 plastic processing companies with a solid reputation of 30 years of know-how (Rovipharm, Eskiss, Stiplastics). The different facilities are certified ISO 13485, including clean rooms The SGH Medical Pharma group designs and produces innovative solutions for : - Drug and supplement administration for solid and liquid medicines : dosing syringes, measuring cups and spoons, single doses, pipettes for droppers and pill dispensers... - Pharmaceutical use : plunger for pre-filled syringes, pre-filled syringes... - IV diagnostics …

Type: SMB Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

Take care of the ergonomics of health products! Specialists in the ability to use medical devices. We help you design a relevant, intuitive, safe and pleasant to use product USeconcept supports you in the management of ergonomics in the design and improvement phases of your products and services. Specializing in usage innovations, we have special expertise in medical IT, medical devices as well as new technologies related to trade. We help you better understand the needs of your users and design a complete, intuitive, safe and pleasant product. These characteristics are now increasingly required by regulations and constitute an essential …

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

"Where MRI meets Safety" HEALTIS is an experienced MRI safety and compatibility company located in Nancy, France. We are ISO/IEC 17025 accredited* and provide expert services in the following fields: • MRI Safety and Compatibility Assessment of Medical Devices (MRI safety testing laboratory) • Numerical Modeling • MRI Safety and Compatibility Training • Technical and Regulatory Support related to MRI Safety and Compatibility We perform tests in compliance with the following international standards: ASTM F2052 · ASTM F2213 · ASTM F2182 · ASTM F2119 · ASTM F2503 · ISO/TS 10974; and are an active participant in international normative groups. Additionally, …

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

We produce customised chemical proteins to help our bio-pharms partners to accelerate their projects. 🧪 X’PROCHEM is a biotech company who invented an advanced and proprietary ligation technology. We help our bio-pharma partners design and create therapeutic, vaccine and diagnostic proteins. Unlike recombinant fermentation we can produce proteins containing up to 400 amino acids, without isoforms, endotoxins, or biological contaminants. We co develop solutions with our partners to understand the real needs within the context. By working closely, we can adapt to changing needs and circumstances. protein, purification, synthesis, protein production, peptide synthesis, and life sciences

64 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

CNS/PNS - In vitro - In vivo - Drug Development Neuro-Sys is a research-intensive and innovative organisation specialising in pharmacology and in advanced in vitro and in vivo models of neurodegenerative diseases, mode of action research, and drug development in the CNS and PNS fields. We provide pharmacological profiles of lead compounds and explore their underlying mechanism of action and studies to determine the neuroprotective activity. We’re dedicated to providing high-level technical expertise in a collaborative relationship with our clients and accompany you along the drug development stages, from preclinical to clinical. Our expertise: › Alzheimer’s disease (AD) › Parkinson’s …

33 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

15 years of Quantitative Pharmacology Solutions applied to the development of drug candidates. PhinC Development is the PK Modeling & Simulation partner for small to medium sized pharmaceutical or biotech companies, who need to move forward in early drug research. Based on Model-Informed Drug Development, PhinC helps you to increase the confidence in decision making and reduces cycle time of your development. Our mission consists in developing the best models to take advantage of all the research data at every phase (in vitro, in vivo animal and human) and carry out robust simulations and predictions requested and recommended by the …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Innovative technology, safer outcomes. IDMED, a French company based in Marseille, develops and markets innovative medical devices in the fields of anesthesia and intensive care. Our products are used worldwide in operating theaters, intensive care units, neuro-ophthalmological consultations and research laboratories. Follow us on Facebook as well https://www.facebook.com/profile.php?id=100087269760737 Our products are commonly used in the areas of pupillometry, neuromuscular blockade monitoring and analgesia monitoring. IDMED develops products in collaboration with healthcare professionals. Innovation, reliability and relevance are the core qualities of our devices. We put our technical knowledge to the service of an improved everyday clinical practice. Healthcare, Medical device, …

96 similar entities Type: Startup Activities: deeptech manufacturing healthtech Technologies: Synthetic Biology

Physioassist Develops and Markets Simeox, an innovative airway clearance Device for patients with cf, copd, be Physioassist is a medical equipment company that has developed expertise in rheology, study of bronchial mucus physics. After several years of research, an effective pneumatic vibration signal was characterized to act on intra pulmonary mucus, liquefy and drain it. This signal is issued by the Simeox medical device, which stimulates bronchial mucus by successive depressions, while ensuring passive expiration. Simeox is intended for patients with chronic respiratory pathologies. COPD, Airway Clerance, Respiratory Device, and CYSTIC FIBROSIS

Type: Startup Activities: healthtech manufacturing deeptech Technologies: Synthetic Biology

REGULATORY AFFAIRS SPECIALISTS AND REGISTRATION HOLDER MANDALA International offers consulting and operational support for healthcare-related companies seeking to develop their business in Latin America with a special focus on Brazil, Mexico and Colombia. Apart from this, we provide support for CE mark to enter European countries. MANDALA International is the world’s leader for Medical Device & Pharmaceutical Registration in Brazil (ANVISA), Mexico (COFEPRIS), Colombia (INVIMA) and Europe (CE). It is the only service provider authorized to import and distribute drugs in Brazil (Brazilian Registration Holder) and to run an ANVISA-approved laboratory to register pharmaceuticals. MANDALA specializes in the healthcare industry …

Type: SMB Activities: deeptech healthtech regtech Technologies: Synthetic Biology

AYOXXA – the Translational Proteomics Company. Understanding complex biology from bench to bedside. AYOXXA - The translational proteomics company AYOXXA Biosystems GmbH, based in Cologne (Germany), is an international biotech company focused on the development of its proprietary beads-on-a-chip technology for advanced protein analysis. LUNARISTM. AYOXXA’s innovative multiplex protein analysis platform is a fully integrated system designed for the parallel analysis of multiple biomarkers in picogram amounts of biological samples, allowing scientists to gain a maximum of high quality and reproducible insights. LUNARISTM is fully scalable, with integrated, image-based quality control and transparent data processing and management, enabling translational proteomics …

12 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Nourish your mind. *Closed company* Fedmind is a health application for therapeutic education of overweight or obesity patients. An actor in the field of prevention and in that of medical research, Fedmind works in order to offer different, complementary and global care of the disease. The application offers on a complete one -year program with online therapy to work on the causes of obesity, food education education and physical activity circuits adapted to overweight. With the help of a benevolent community through weekly support groups, monitoring by the care team via the application and Fedalert ', a tool to disarm …

Type: SMB Activities: healthtech Technologies: Synthetic Biology

Access to music for all audiences in medico-social establishment Starting from the observation of an INSEE study indicating that listening to music is the favorite activity of the elderly, and the fact that residents in retirement establishments have little access to music that has gone through their lives, the company Eleze Plus has developed and markets a real "interactive terminal for retirement homes": the Mélo terminal. The Mélo terminal contains from 2000 to 4000 titles from yesterday and today, its design was designed to allow use by all, while considering practical aspects such as the ease of cleaning or moving …

Type: Startup Activities: entertainment silvertech Technologies: Synthetic Biology

Serving patients and research. French hub of medical and dermo-cosmetic cannabis innovation Created in 2014 by a patient, Delled develops lafleur laboratories, the first French pharmaceutical laboratories specialized in medical cannabis & amp; Hortimind, a plant production solution assisted by AI. Lafleur aims to promote the research and development of medical cannabis in France and to the international and to defend the evolution of the legal framework relating to the production, culture and use of cannabis for medical use. Laboratories cultivate, transform, control and manufacture medicines based on medical cannabis in the context of research and development in France. Healthy …

5 similar entities Type: Startup Activities: manufacturing deeptech healthtech biotech Technologies: Synthetic Biology

Relax "Bonne Mood Diffuser" ® An alternative to medication in the management of stress and anxiety. Relax, the fruit of collaboration with experts in interventional cardiology, has been developed to meet the needs of medical services. This innovative therapeutic reality solution aims to alleviate stress and anxiety associated with anxiety -provoking situations, including medical care and interventions. Designed with 2D relaxation glasses, Relax technology offers an approach without side effects, adapted to a large audience. These glasses can be used preventively before medical procedure during it to soothe patient anxiety, and after in order to promote emotional recovery. Their usefulness …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

BariaTek is a clinical stage company dedicated to treating obesity via a reversible non-invasive endoscopic approach. BariaTek Medical is a clinical stage company dedicated to addressing obesity via minimally invasive endoscopic approaches. Obesity is one of the most debilitating pandemics affecting humanity: More than 2 billion people are overweight of which 1 billion suffer from obesity. People suffering from obesity tend to lead shorter, less healthy, lives. Treating overweight-related conditions (diabetes, hypertension, sleep apnea and others) is projected to cost G-20 nations on average 8.7% of their health budgets over the next three decades which is estimated by the United …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

https://t.co/YVyBFPnY4V

Type: SMB Activities: deeptech Technologies: Synthetic Biology

23andMe is a leading consumer genetics and research company. Founded in 2006, the company’s mission is to help people access, understand, and benefit from the human genome. 23andMe has pioneered direct access to genetic information as the only company with multiple FDA authorizations for genetic health risk reports. The company has created the world’s largest crowdsourced platform for genetic research, with 80 percent of its customers electing to participate. The 23andMe research platform has generated more than 180 publications on the genetic underpinnings of a wide range of diseases, conditions, and traits. More information is available at www.23andMe.com Chapter 11 …

Type: Large company Activities: biotech deeptech Technologies: Synthetic Biology

DYSIS is computer-aided colposcopy with cervical mapping that helps healthcare professionals detect cervical lesions. DYSIS® is computer-aided colposcopy with innovative cervical mapping that quantifies acetowhitening and creates the color-coded DYSISmapTM to help healthcare professionals detect cervical lesions. The IMPROVE-COLPO study demonstrated an increased detection of patients with high-grade lesions by 44% when the DYSISmap was used for biopsy selection after a thorough visual colposcopic assessment. Additionally, high-resolution images, video (including exam playback) and a patient report improve documentation, patient communication and help healthcare professionals direct patients with greater assurance for screening, treatment or conservative management using SMARTtrackTM, a side-by-side comparison …

Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

AbLeads is a young biotech startup developing innovative solutions in Oncology, through the generation of novel, personalized therapeutic antibodies. Learn More on https://ableads.fr Biotechnology, Oncology, Immunotherapy, Therapeutic Antibodies, and Personalized Medicine

574 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Our Services are as Unique as Your Discoveries ANS Biotech is a preclinical CRO fully dedicated to the in vivo pharmacology of pain. Since 2006 we have serviced more than 160 worldwide clients from Pharma and Biotech to build their preclinical portfolio, assisting in the positioning / repositioning of their analgesic products within precise product profiles. As your partner we work as an extension of your scientific team. We support your drug discovery and development efforts by offering: - SCREENING IN PAIN to profile your drug candidates - MODELS & TESTS IN PAIN: tailored solutions for the management of your …

10 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Experts in medical devices design & development, quality assurance and regulatory affairs. Design, development and manufacturing of medical devices, from class I to class III. Consulting on Quality Assurance and Regulatory Affairs ISO 13485 : 2016 certified company by French Notified Body GMED. Registered with the FDA. Affaires réglementaires, Conseil en qualité, and Conception de dispositifs médicaux classe I à III

80 similar entities Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

Miravas is an innovative medical devices start up in varicose veins treatment Soon a new device for the treatment of venous disease in medical office setting, with combination of two complementary techniques, steam and radiofrequency Varicose veins treatment, Medical devices, and Thermal ablation

60 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Creative Technologies for Efficient Therapeutics, Precision medicine Inoviem Scientific is a private Bioanalytical company which delivers enabling information to secure drug discovery programs and to take informed decision by closing the gap between preclinical and clinical development. We reconcile translational pharmacology and human physiology by using fresh patient material from the target cohort, embracing the complexity of human diseases. Inoviem's enabling technologies are working in pathological conditions to get the treatment in development to the right patient. Our indication-agnostic access to patients combined with innovative label-free platforms deliver Target identification and validation, targets & Mode of Action deconvolution, patient stratification, …

84 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Dermo-innovation Feeligreen is a technology startup developing safe and effective micro-current devices for a wide range of cosmetic and therapeutic applications. With applications ranging from anti-ageing to wound healing, it develops and sells innovative drug-delivery systems to TIer1 pharmaceutical laboratories medical devices, therapeutics, cosmetics, and skincare

134 similar entities Type: Startup Activities: healthtech manufacturing deeptech biotech Technologies: Synthetic Biology

NanoMedSyn develops a new delivery platform to create first-in-class drugs by the engineering with patented AMFA vectors NanoMedSyn was born from the fundamental research of its biologist and chemist founders who discovered a breakthrough technology for drug delivery to the lysosomal cell compartment leading to potentiation of therapeutics. This technology, validated at the preclinical level, has a wide range of applications in the fields of oncology, immunity, inflammation or metabolism. NanoMedSyn’s development plan is based on a strong intellectual property of patented synthetic derivatives called AMFA. The main application is the engineering of recombinant proteins like antibodies or enzymes for …

156 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Engineering a Sustainable Future We are a strain development company. We engineer purpose-built secondary genomes that facilitate the bio-production of high value chemicals and enzymes. Inline with the circular economy, we are currently establishing a biorefinery that uses second generation sustainable feedstocks for fermentations. Biotechnology, Genome Engineering, Synthetic Biology, pigments, and fermentation

103 similar entities Type: Startup Activities: cleantech deeptech greentech Technologies: Synthetic Biology

Advancing healthcare through innovative adenosine receptor-based drugs Palobiofarma S.L. is a Spanish biopharmaceutical company dedicated to discovering and developing innovative drugs based on the modulation of adenosine receptors.

226 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Focusing on innovation for health solutions since 1990, Stragen is a global player in the development, registration and distribution of Generic drugs and Consumer Health products. Starting as a small API trading platform 30 years ago in Geneva, Switzerland, today Stragen operates in over 60 markets through a network of dynamic and collaborative partners, employing over 150 people and working with 10 dedicated affiliates worldwide. As a result of decades of experience and expertise in R&D, combined with our continuous commitment to advancing public health, we invest in the fundamental research through to the delivery of innovative and trusted health …

52 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

Champions of science, on a mission to rebalance the world from the microbial world up! Noblegen is an advanced digital biology company that employs microorganisms to reshape the world’s linear food systems with efficient and affordable circular solutions. We are champions of science on a mission to reinvent our future and disrupt conventional practices to rebalance planet and life, using microbes and fermentation technology. In our first phase of commercialization we have reinvented the world’s approach to food & agriculture. Our next phases of commercialization include biomaterials, health, energy, and space, among other industries. The company currently employs over 55 …

34 similar entities Type: SMB Activities: it services Technologies: Synthetic Biology

Air-Tite Products is a company of syringe and needle experts, specializing in hypodermics since 1926. We focus on providing personalized service to our customers and distinguish ourselves with hard-to-find niche products. Air-Tite Products is a direct importer of high-quality products from global leaders in more than 10 different countries. Whether you need an off-the-shelf solution from our hundreds of stocked products, or to leverage the capabilities of our manufacturing partners for a custom solution, Air-Tite can identify options that best meet your individual application’s requirements. We supply hypodermics to diverse industries from human healthcare to pharmaceuticals, animal health, laboratory, industrial, …

Type: SMB Activities: spacetech Technologies: Synthetic Biology

Innovation Partners for Life. AVNA (formerly OKAY Industries) is a contract manufacturing partner for leading medical device OEMs. We produce high-quality, complex components and sub-assemblies for precision powered, robotic, and mechanical medical and surgical devices. Our fully-integrated services and continual investment in advanced technology have positioned us as a market leader in metal forming, Multi-Axis CNC and Laser-Swiss machining, laser processing, plastic injection and over-molding, micro-machining, metal stamping, and automated assemblies. A wide variety of in-house manual, semi, and fully automated parts cleaning and finishing services combined with machine design, build, and automation technologies allow us to customize solutions that …

19 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

User Centered Solutions in HF, UX & ID Metaphase in now a part of Aptar . Our user centered consulting services bring together expertise in industrial design & research, user-experience & human factors, market insights & program development, product development & commercial scale-up and launch & post market optimization. * Specialist in high-touch products * Experts in HF & Research * Global network of usability labs * World class medical device solutions * Brand success and launch readiness * End to end enterprise-wide solutions provider ergonomics, strategy, research, product development, design, ergonomic design, product design, packaging design, ergonomic design audits, …

50 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

The Premier Business Development Association for the Global Bio/Pharmaceutical Manufacturing Value Chain Founded in 1890, the Drug, Chemical & Associated Technologies Association, Inc. (DCAT) is a not-for-profit, corporate member-supported, and volunteer-led global business development association for companies engaged in the Bio/Pharmaceutical manufacturing value chain. DCAT has been providing a life-long collegial community for its Member Companies, and their representatives, for over 130 years. DCAT helps build relationships within its unique member company profile that includes the Bio/Pharmaceutical industry’s entire manufacturing value chain. DCAT creates objective, expert-driven education programs and informational services so its Member Companies can easily gain insight into …

Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech edtech Technologies: Synthetic Biology

LAUS - The GLP Lab - Where Science meets Expertise LAUS is an internationally recognized GLP certified testing facility (CRO) working in six areas of expertise: Analytical Chemistry, Physico-Chemistry, in vitro–Toxicology, Mutagenicity/Genotoxicity, Ecotoxicology, and Environmental Fate. LAUS provides a strong portfolio of studies in all six areas for a great variety of products like chemicals, pesticides, biocides, medicinal products for veterinary and human use, cosmetics, food additives, and novel food. These tests are crucial for 1. registration purposes (e.g. REACH, BPR), 2. classification (e.g. GHS, CLP, Water Hazard Classes), 3. application for labeling (e.g. Ecolabel), 4. assessment of potential health …

Type: SMB Activities: biotech deeptech foodtech healthtech Technologies: Synthetic Biology

SUDOSCAN - Early detection and follow-up of autonomic neuropathy Impeto Medical SAS markets SUDOSCAN, a Class IIa Medical device regulated under the CE certification.

Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

You take care of others, we take care of you. SMICES is a european company based in Montpellier, which offers innovative, smart, and effective solutions, to the challenges encountered in the medical and surgical field. SMICESs commitment: improve the well-being of surgical teams and the safety in the operating theatre, in order to provide better patient care. SMICES works side by side with surgeons to develop the best medical devices, suitable for use in the operating room. For some years, the problem of the surgical smoke hazards during laparoscopy is raised. These smokes contain harmful substances and cause visual and …

Type: SMB Activities: healthtech Technologies: Synthetic Biology

Axience was created in 2001 and became a veterinary pharmaceutical operator in 2005. Portfolio of drugs, princeps and generics, intended for pets, equine, cattle and pigs Very high specialization in hygiene and disinfection of veterinary clinics since 2003 and in anesthesia and analgesia all species since 2009. Anesthesia, disinfection, veterinary biocides, and analgesia

16 similar entities Type: SMB Activities: foodtech Technologies: Synthetic Biology

Creator of Sonovein®: The Only Non-Invasive Varicose Vein Treatment Theraclion is the French MedTech company behind the Sonovein®, the only non-invasive varicose vein treatment. Robotic-driven, Sonovein® is powered by High Intensity Focused Ultrasound (HIFU). It does not require incisions nor an operating room, leaves no scars, and allows patients a quick return to their daily activities. The CE-marked platform has the potential to replace millions of surgical procedures every year. In the United States, Sonovein® is an investigational device limited to investigational use; it is not available for sale in the U.S. Based in Malakoff (Paris), the Theraclion team is …

Type: SMB Activities: healthtech deeptech Technologies: Robotics Synthetic Biology

Creating a global leader in extended phage therapies PHAXIAM is a biopharmaceutical company developing innovative treatments for resistant bacterial infections, which are responsible for many serious infections. The company is building on an innovative approach based on the use of phages, natural bacterial-killing viruses. PHAXIAM is developing a portfolio of phages targeting 3 of the most resistant and dangerous bacteria, which together account for more than two-thirds of resistant hospital-acquired infections: Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa. PHAXIAM is listed on the Nasdaq Capital Market in the United States (ticker: PHXM) and on the Euronext regulated market in Paris …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer. Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need. Innate has been a pioneer in the understanding of natural killer cell (NK cell) biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical …

67 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Establishment of excellence expert in the SMR management of neurological conditions The Germaine Revel Medical Center (CMGR) is an ESPIC of medical care and rehabilitation (SMR) specialized in the ailment of the nervous system, managed by the Germaine Revel foundation. It is located in a green setting in the Monts du Lyonnais in Chabanière (69440) halfway between Lyon and Saint-Etienne. Its hospital capacity is 83 beds and places made up of full and week hospital units, a day hospital, a respite unit (SLA) as well as 8 beds dedicated to EVC-EPR patients. Each year, more than 800 patients suffering from …

Type: SMB Activities: healthtech Technologies: Synthetic Biology

Reshaping RecoveryTM Established in 2015 and based in France, SafeHeal is a clinical stage medical device manufacturer. Specializing in the development of anastomosis protection devices for colorectal surgery, SafeHeal’s premier device, Colovac, was invented to eliminate the need for diverting ostomies in patients undergoing colectomy. medical device

16 similar entities Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

The RNA Platform - by analyzing RNA we can detect disease, monitor health and design the Next Generation Cures Today only 1 out if 4 cancer drugs prolongs life because we treat all the patients the same way. Genomic Expression’s OneRNATM test can save lives and make healthcare delivery more effective by sequencing RNA and linking RNA’s to approved therapies and clinical trials. Genomics, information, personalized medicine, personalized diagnostics, Sequencing, prognostics, bioinformatics, sample preparation, Next Generation Sequencing, Biobank, Access to biological samples, target filtering, RNA-seq, RNA sequencing, and RNASeq of FFPE samples

102 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

The new tool of hand, wrist, and fingers rehabilitation through a tablet device ReHand is a hand rehabilitation app that qualifies as a Class I medical device. hand therapy, terapia de mano, telerehabitation, and telerehabilitación

17 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Insect Waste Management SolutionsTM Founded in 2021, Flybox® builds and support modular insect farms that turn the waste we already have into food supply we dearly need. Leading edge food & organic waste businesses deploy Flybox® technology on-site to upcycle organic waste into insect protein and fertiliser, to use or sell. With bases in the UK and Kenya, Flybox® technology enables global adoption of insect-farming technology for a wide range of use cases. Flybox® is the future of sustainable food production, today. insect farming, black soldier fly, Agritech, African startup, Insect technology, and black soldier fly technology

Type: Startup Activities: foodtech Technologies: Synthetic Biology

"Treating Tumors from the Inside" - Intra-tumoral delivery of oncology drugs OncoLize (NL) develops intra-tumoral drug depots to "Treat Tumors from the Inside". This means clinicians can inject and keep certain drugs where they are most effective: inside the tumor mass. Our patent protected ChemoGell(TM) platform is based on hydrogel technology, an awesome injectable drug depot platform developed at RCSI, Dublin by prof.dr. Helena Kelly and her team. We have an exclusive, world wide license for oncology. The base-patents have recently been granted in US, EU, China and Japan, with more in the pipeline. With the Gastro-Oncology team at Leiden …

12 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Simpler joint replacement surgery. Biomimetic printing technology. Osteoarthritis causes chronic pain for 33% of the population and is treated with joint replacement. 1.3M knee replacements are performed globally every year - 450,000 of them are in young patients with high risk of failure and revision surgery. These patients experience poorer outcomes so surgeons are reluctant to treat them. OSSTEC has developed an additive manufacturing bone healing technology, currently applied in partial knee implants. Our implants stimulate long-term bone growth to resolve common sources of failure: loosening and bone loss. Our vision is to keep patients active, pain-free and enjoying added …

Type: Startup Activities: it services Technologies: Synthetic Biology

Where remarkable journeys start Daytot is an innovative early intervention brand, developing life-enhancing products aimed at improving the developmental outcomes for babies with delayed development. We are a company with heart, using innovation and research to create and introduce developmental products into a baby's daily routine from day one. Working with the best minds in the world, we collaborate through research & design, to unlock new insights and create groundbreaking products, to support babies in achieving milestones with comfort and purpose. Our therapist-approved products are uniquely designed for hospital and home use. Working closely with neonatal and paediatric therapists, we …

3 similar entities Type: Startup Activities: manufacturing deeptech Technologies: Synthetic Biology

The native drug discovery enablers for complex targets. Let's pioneer together! Cube Biotech is a contract research organization of membrane protein scientists offering non-GMP services for many applications. We assist in protein preparation, biophysical target characterization, and structure determination by cryo-EM or assay development. Our USP is a vast synthetic copolymer portfolio, enabling more reliable membrane protein research. Copolymers offer, in contrast to detergents, a broad and native picture of your target. Discover endless customization possibilities with our Protein Services – your project, your way, as easy as building with Lego bricks! Build frameworks that are easily incorporated into your …

20 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

NEXT GENERATION OF CATHETERS Health is the level of functional or metabolic efficiency of a living organism. In humans it is the ability of individuals or communities to adapt and self-manage when facing physical, mental or social challenges. Health, medical devices, stroke, and thrombectomy

114 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Making medicines differently to bring better drugs faster to the patients who benefit most with ML and data at scale. insitro is a data-driven drug discovery and development company that leverages machine learning and high-throughput biology to transform the way medicines are created to help patients. At insitro, we are rethinking the entire drug discovery process, from the perspective of machine learning, human genetics, and high-throughput, quantitative biology. Over the past five decades, we have seen the development of new medicines becoming increasingly more difficult and expensive, leaving many patients with significant unmet need. We’re embarking on a new approach …

41 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Synthetic Biology

Precision in Cancer Diagnostics oncgnostics develops – based on proprietary epigenetic biomarkers - highly reliable molecular in vitro diagnostic (IVD) tests for screening, follow-up care and therapeutic decisions in cancer diagnostics. Diagnostik, Epigenetik, Medizin, Assay Development, Diagnostics, DNA-Methylation, Medicine, and LifeScience Developments

123 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Building Better Biology At MarraBio we design, engineer and construct bacterial protein polymers, that contain the biological messages that cells need to grow, divide and behave properly. Cells grown on an industrial scale for research, agricultural or therapeutic use need to be supplied with the right signals. We provide a multi-functional, cost effective solution in a single, easy to use material. Find out more at https://www.marrabio.com/ Protein Engineering, Protein Production, Cellular Agriculture, Cultivated Meat, Research Reagents, Stem Cell Expansion, and Industrial Scale Cell Culture

138 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Developing the Next Generation Gene Editing Technology Pencil Biosciences is developing a truly innovative gene modulation technology that can have an impact across a range of applications, including new therapeutic options for patients with rare diseases. Genome Engineering, Research and Development, and Gene Editing

299 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Therapeutics In-Motion A Biomedical Company Improving Drug Accumulation In Cancer Cells

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

a biopharmaceutical company focused on developing allosteric modulators for the treatment of neurological disorders Neurosterix is a biopharmaceutical company focused on developing allosteric modulators for the treatment of neurological disorders. Our drug discovery and development platform identifies and develops allosteric modulators — molecules that increase or decrease the activity of target receptors by binding outside of the “active site” where endogenous ligands and traditional drugs operate. Through this platform, Neurosterix’s novel drug candidates have the potential to provide medicines with improved efficacy, safety and tolerability for patient communities suffering from underserved neurological disorders.

Type: Startup Activities: legaltech Technologies: Synthetic Biology

REINVENTING CARDIAC DRUG DISCOVERY HeartBeat.bio (HBB) is an emerging TechBio company developing a next-generation drug discovery platform for heart diseases. Our so-called Cardioid Drug Discovery Platform is based on a proprietary iPSC-derived single and multi-chamber cardiac organoid model. We combine this unique human biology with state-of-the-art hardware solutions to industrialize the organoid cultivation and screening process as well as AI-supported software for high-content and big data analysis. HBB pursues an end-to-end human-centric drug discovery approach along the entire pre-clinical value chain: Starting with target identification and validation, disease modeling, hit identification and confirmation, leading up to compound development and profiling …

13 similar entities Type: Startup Activities: deeptech Technologies: SaaS Synthetic Biology